Eric Hyllengren | Investor Relations |
Pascal Touchon | President and Chief Executive Officer |
Utpal Koppikar | Chief Financial Officer |
Joe Newell | Chief Operations Officer |
A.J. Joshi | Chief Medical Officer |
Jakob Dupont | EVP and Global Head of Research and Development |
Kristin Yarema | Chief Commercial Officer |
Salim Syed | Mizuho Securities |
Benjamin Burnett | Stifel |
Marc Frahm | Cowen & Company |
John Newman | Canaccord Genuity |
Samantha Semenkow | Citigroup |
Robert Andrew | William Blair & Company |
Michael DiFiore | Evercore ISI |
Tessa Romero | J.P. Morgan |
Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please be advised that today's call is being recorded. I would now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Thank you. Please go ahead, sir.